Buttock Implants in Ghana
Buttock Implants in Ghana section, includes general infrmation about Buttock Implants Procedure, Ghana Buttock Implants Local News, Ghana Buttock Implants Surgeon Locator and other Buttock Implants related material.
Ghana Buttock Implants - The Plastic Surgery Procedure
This surgical procedure also called gluteoplasty or buttock augmentation. It is designed to reshape the size of your buttocks and create more firm and aesthetic appearance. The buttock area is not easily changed by weight reduction or exercise, therefore you may consider this operation to improve the look of your buttock. In general, every person wishing to undergo the operation, and is in a good physical condition, can do so.
During the operation the surgeon inserts silicon implants into your gluteal area. Unlike breast implants, these are soft and solid, their shape and size vary, according to individual body form and desires.
Ghana Buttock Implants - The Implants
There are few kinds of implants: round or oval (also called an anatomic implant). The most common implants are those made of silicon. It comes with a smooth or textured surface and they are solid (meaning: they rarely spill or rupture). The selection of an implant is usually made according to the surgeon's advice and your preference.
Ghana Buttock Implants - Insertion Locations
The incision for the implant insertion can be made in several locations: two excisions, either on the superior buttocks or inferior buttock near the posterior thigh. Both incisions leave a quite visible scar. One excision is made in the sacrum area, it goes from top down, and is usually small (4-6cm). The only problem is that such incision tends to become infected more often; this can be treated with antibiotics. The implant can be placed above or below the gluteal muscles. Finally, a liposuction can be added to this procedure to further shape your buttocks.
This procedure is preformed under general anesthesia and usually lasts one hour, liposuction may require an additional half hour (consult local Ghana surgeon).
Ghana Buttock Implants - Risks
Every procedure has its risks: this one includes bleeding, infection, nerve and/or muscle damage and damage to the implants, such as silicon spillage and buttock asymmetry.
Ghana Buttock Implants - After Surgery
After surgery you will feel pain and discomfort, and you will be prescribed with painkillers. You also have to wear a special bandage for 2-3 weeks to help your buttocks gain their new look. Occasionally you may feel either temperature changes or numbness in the area. This will resolve after a few months. It may take about 3 months for the swelling to resolve and the buttocks to regain their final appearance. You'll be able to go back to full activity after one month. Since the implants are placed far from the bony area you will have no trouble sitting. Finally, the implants will give your butt the look like you have been working out for years.
Other Ghana Body Procedures
All Body Procedures
Ghana Buttock Implants (current)
Ghana Buttock Augmentation
Ghana Liposuction
Ghana Vaginal Surgery
Ghana Body Cotouring
More Ghana info...
Ghana By plane There are scheduled domestic flights 2 - 3 times a day between Accra, Kumasi, Sekondi and Tamale in the north including flights by Antrak Air. There are also filghts to destinations outside the country.
Ghana By train There are rail links between Accra, Takoradi and Kumasi. The train is very slow and it travels at night so you won't see much.
Plastic Surgery News...
- Four days' exposure to a REM sleep deprivation procedure reduces cell proliferation in the part of the forebrain that contributes to long-term memory of rats, according to a study published in the February 1 issue of the journal SLEEP.The study, authored by Dennis McGinty, PhD, of the V.A. Greater Los Angeles Healthcare System, focused on male Sprague-Dawley rats.
- Though treatment of secondary hyperparathyroidism with activated vitamin D analogues is linked to better survival in patients on dialysis., it is unknown if this is the case for patients with chronic kidney disease (CKD) not on dialysis. Therefore, researchers examined the link between oral calcitriol treatment, mortality and the incidence of dialysis in 520 male US veterans (mean age, 69.8 years; 23.5% black) with CKD stages 3 to 5, not yet receiving dialysis (mean estimated GFR 30.8 ml/min). Adjustments were made for age, race, comorbidities, smoking, BP, BMI, use of phosphate binders, estimated GFR, proteinuria, white blood cell count, percentage of lymphocytes, and levels of PTH, calcium, phosphorus, albumin, bicarbonate, and haemoglobin.
In the study, 258 patients received calcitriol, 0.25 to 0.5mcg/d, for a median duration of 2.1 years. The incidence rate ratios for mortality and combined death and dialysis initiation were statistically significantly lower in treated vs. untreated patients (0.35; 95% CI, 0.23 to 0.54; p < 0.001 and 0.46; 0.35 to 0.61, respectively) in the fully adjusted models. These results were consistent across different subgroups.
The researchers conclude that treatment of secondary hyperparathyroidism with calcitriol in patients with CKD stages 3 to 5 not yet on dialysis appears to be linked to statistically significantly greater survival. However, they acknowledge that RCTs are required to verify these observations and examine whether similar associations are seen with different activated vitamin D analogues.